Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Biomed Research International|December 31, 2014
Protective effect of a lipid-based preparation from Mycobacterium smegmatis in a murine model of progressive pulmonary tuberculosisMaria de los Angeles García, Reinier Borrero, Maria E Lanio, et al.
Antimicrobial Agents and Chemotherapy|February 27, 2019
Fluoroquinolone Efficacy against Tuberculosis Is Driven by Penetration into Lesions and Activity against Resident Bacterial PopulationsJansy Sarathy, Landry Blanc, Nadine Alvarez-Cabrera, et al.
Tuberculosis (Edinburgh, Scotland)|November 21, 2016
Mycobacterium smegmatis proteoliposome induce protection in a murine progressive pulmonary tuberculosis modelYanely Tirado, Alina Puig, Nadine Alvarez, et al.
ACS Infectious Diseases|January 18, 2019
Investigation of ( S)-(-)-Acidomycin: A Selective Antimycobacterial Natural Product That Inhibits Biotin SynthaseMatthew R Bockman, Curtis A Engelhart, Julia D Cramer, et al.
Antimicrobial Agents and Chemotherapy|January 31, 2022
A Rabbit Model to Study Antibiotic Penetration at the Site of Infection for Nontuberculous Mycobacterial Lung Disease: Macrolide Case StudyFirat Kaya, Jacqueline P Ernest, Katherine LoMauro, et al.
ACS Infectious Diseases|January 27, 2023
Synthesis and Testing of Analogs of the Tuberculosis Drug Candidate SQ109 against Bacteria and Protozoa: Identification of Lead Compounds against Mycobacterium abscessus and Malaria ParasitesMarianna Stampolaki, Satish R Malwal, Nadine Alvarez-Cabrera, et al.
Viruses|July 27, 2024
Novel Pan-Coronavirus 3CL Protease Inhibitor MK-7845: Biological and Pharmacological ProfilingNadine Alvarez, Gregory C Adam, John A Howe, et al.
Nature|December 11, 2024
Small-molecule inhibition of SARS-CoV-2 NSP14 RNA cap methyltransferaseCindy Meyer, Aitor Garzia, Michael W Miller, et al.
Journal of Medicinal Chemistry|February 16, 2024
Invention of MK-7845, a SARS-CoV-2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine MimicValerie W Shurtleff, Mark E Layton, Craig A Parish, et al.
Pageof 3